FPA March 2022 Central
https://issuu.com/communityadvocate/docs/fpa_march_22_central_web
Medicare To Limit Coverage Of New Alzheimer’s Drug
By Brett Peruzzi, Managing Editor
Region - Aduhelm, the Alzheimer's disease treatment approved last summer by the Food and Drug Administration (FDA), has run into...